3.03 USD
↘ 0.22 (6.77%)AT CLOSE (11:59 AM EDT)
Perspective Therapeutics, Inc.
CATXAMEX • USD
3.09
↗ 0.06 (1.98%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
3.09
↗ 0.06 (1.98%)
Market: CLOSED
Open?$3.25
High?$3.29
Low?$3.01
Prev. Close?$3.25
Volume?1.9M
Avg. Volume?1.5M
VWAP?$3.10
Rel. Volume?1.27x
Bid / Ask
Bid?$3.04 × 300
Ask?$3.20 × 300
Spread?$0.16
Midpoint?$3.12
Valuation & Ratios
Market Cap?345.6M
Shares Out?114.0M
Float?62.0M
Float %?83.4%
P/E Ratio?N/A
P/B Ratio?0.99
EPS?-$0.97
Dividend?0.00%
Ex-Dividend?N/A
Perspective Therapeutics, Inc. (CATX) trades at $3.03 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, CATX trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Employees
166
Market Cap
345.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2003-12-29
Address
2401 ELLIOTT AVENUE
SEATTLE, WA 98121
Phone: 206-676-0900
SEATTLE, WA 98121
Phone: 206-676-0900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?29
Momentum?3
Short Sent.?25
Piotroski F-Score?1/9Weak
Altman Z-Score?1.79Distress
Confidence?72%Moderate
Short InterestSqueeze Risk
Short % of Float?20.36%Squeeze Risk
Short Interest?12.6M
Days to Cover?8.0
Free Float62.0M
Avg Daily Volume1.6M
Settlement Date2026-05-15
Financial Health
Current Ratio?8.75Strong
Quick Ratio?8.75Strong
Cash Ratio?1.71Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?0.99CHEAP▾
Peers100
S&P97
P/S?559.16HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.5CHEAP▾
S&P97
EV/Sales?474.43HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-32.0%WEAK▾
S&P6
ROA?-27.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-107447000
Enterprise Value?$293.2M
Fundamentals ratios updated end of day